Answer to Question 1
Correct Answer: 2
Rationale 1: The Dietary Supplement Health and Education Act required labeling of supplements.
Rationale 2: In 2007, the FDA passed the current Good Manufacturing Practice (cGMP) regulations, which mandated manufacturers to evaluate supplements for purity, strength, and composition.
Rationale 3: The FDA's Division of Dietary Supplement Programs offers guidelines and tips for consumer safety.
Rationale 4: The Food and Nutrition Board of the National Academy of Sciences has established the recommended dietary allowances (RDAs) for healthy adults.
Global Rationale: In 2007, the FDA passed the current Good Manufacturing Practice (cGMP) regulations, which mandated manufacturers to evaluate supplements for purity, strength, and composition. The Dietary Supplement Health and Education Act required labeling of supplements. The FDA's Division of Dietary Supplement Programs offers guidelines and tips for consumer safety. The Food and Nutrition Board of the National Academy of Sciences has established the recommended dietary allowances (RDAs) for healthy adults.
Answer to Question 2
Correct Answer: 3
Rationale 1: Riboflavin (vitamin B2) does not affect the client's level of consciousness.
Rationale 2: Tingling in the extremities is not an expected side effect and should be reported.
Rationale 3: One harmless side effect of large doses of riboflavin is yellow discoloration of the urine.
Rationale 4: Timing of riboflavin (vitamin B2) ingestion is not critical with this supplement.
Global Rationale: One harmless side effect of large doses of riboflavin is yellow discoloration of the urine. This vitamin is nontoxic and does not produce the other effects. Timing of ingestion is not critical.